Compare TKR & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TKR | LNTH |
|---|---|---|
| Founded | 1899 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.4B |
| IPO Year | N/A | 2015 |
| Metric | TKR | LNTH |
|---|---|---|
| Price | $88.62 | $69.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 6 |
| Target Price | ★ $82.70 | $78.00 |
| AVG Volume (30 Days) | 651.0K | ★ 1.1M |
| Earning Date | 02-04-2026 | 02-25-2026 |
| Dividend Yield | ★ 1.54% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.23 | 2.39 |
| Revenue | ★ $4,544,400,000.00 | $1,525,933,000.00 |
| Revenue This Year | $0.37 | $0.01 |
| Revenue Next Year | $3.31 | $0.52 |
| P/E Ratio | ★ $21.51 | $29.12 |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $56.20 | $47.25 |
| 52 Week High | $91.00 | $111.29 |
| Indicator | TKR | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 59.90 | 70.41 |
| Support Level | $84.08 | $66.36 |
| Resistance Level | $91.00 | $67.45 |
| Average True Range (ATR) | 1.76 | 1.67 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 63.12 | 87.43 |
The Timken Co designs and manages a portfolio of engineered bearings and industrial motion products, and provides related services. The Company sells products and services to customers in the following market sectors: industrial distribution, renewable energy, automation, automotive original equipment (OE), agriculture/turf, rail, aerospace, auto/truck aftermarket, construction, etc. The company has two reportable segment: The Engineered Bearings portfolio features bearings with precision tolerances, proprietary internal geometries and quality materials. The Industrial Motion portfolio features products such as drives, breathers, seals, automatic lubrication systems, linear motion products, chain, belts, couplings, etc. Key revenue is generated from Engineered Bearings.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.